1. Gilead's COVID-19 Treatment to Cost $3,120 Per US Patient

    Gilead's COVID-19 Treatment to Cost $3,120 Per US Patient

    Gilead Sciences announced Monday the pricing for its coronavirus treatment remdesivir, saying it will cost $3,120 for a typical U.S. patient with commercial insurance.

    The company announced its pricing plans in preparation for it to begin charging for the antiviral drug in July. The company has been donating doses to the U.S. government for distribution since it received emergency use authorization in May. 

    The drugmaker said it will sell remdesivir for $390 per vial to governments “of developed countries” around the world, and the price for U.S. private insurance companies will stand at $520 per vial. In the U.S., that means Gilead will charge a lower price for government programs like Medicare and a higher ...

    Read Full Article
  1. Categories

    1. News.Law Categories:

      Big Law, Civil Plaintiff, Consumer Law, Coronavirus, Criminal Law, Drug Safety, Employment Safety, Opioids, Political and Legislative, Product safety, Securities, Special Topic, Trucking
    2. Targo:

      F-NRA, Gun Violence
  2. Topics Mentioned